Sotac Pharmaceuticals Ltd (SOTAC) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sotac Pharmaceuticals Ltd on NSE and BSE, with an AI summary of each filing.
Significant movement in price has been observed in Sotac Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Others (Uncategorized) · 03 Nov 2026, 11:03 pm
Sotac Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 13 Nov 2026, 5:30 am
Sotac Pharmaceuticals Schedules Board Meeting on 13th Nov'26 to Consider H1 Results Sotac Pharmaceuticals Limited has informed the exchange that a meeting of its Board of Directors is scheduled to be held on 13th Nov'26. The board will primarily meet to consider and approve the company's half-yearly unaudited financial results for the period ended Sep'26, alongside other general business matters.
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 13 Nov 2026, 5:30 am
Sotac Pharmaceuticals Schedules Board Meeting on 13th Nov'26 to Consider H1 Results Sotac Pharmaceuticals announced that its Board of Directors will meet on 13th Nov'26 to consider, approve, and take on record the unaudited standalone and consolidated financial results for the half year ended 30th Sep'26. Consequently, the trading window for company insiders remains closed from 1st Oct'26 until 48 hours post the declaration of the financial results.
Sotac Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Others (Uncategorized) · 03 Nov 2026, 7:58 pm
Sotac Pharmaceuticals Approves Increase in Authorised Share Capital Sotac Pharmaceuticals Limited announced the voting results of its EGM held on 31st Oct'26. Shareholders approved an ordinary resolution to increase the company's authorised share capital and make consequential alterations to Clause V of its Memorandum of Association. Total votes polled stood at 82,50,400 shares (74.66% of outstanding shares), comprising 80,50,000 promoter shares (100% participation) and 2,00,400 public non-institutional shares (16.97% participation). The resolution passed unanimously with 100.00% votes cast in favour and zero votes against or invalid.
Sotac Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on October 31, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Nov 2026, 10:11 pm
Sotac Pharmaceuticals Shareholders Approve Increase in Authorised Share Capital Sotac Pharmaceuticals Limited announced the voting results of its EGM held on 31st Oct'26. Shareholders approved an ordinary resolution to increase the company's authorised share capital and make consequential alterations to Clause V of the Memorandum of Association. The resolution passed with 100% approval, securing 8,250,400 votes in favor (representing 74.66% of the total 11,050,000 outstanding shares) and zero votes against. Total turnout comprised 8,050,000 promoter shares (100% turnout) and 200,400 public non-institutional shares (16.97% turnout), with no institutional participation or invalid votes recorded.
Sotac Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on October 31, 2026
Annual General Meeting · 31 Oct 2026, 9:38 pm
Sotac Pharmaceuticals Concludes EGM to Increase Authorised Share Capital Sotac Pharmaceuticals held its Extra-Ordinary General Meeting on 31st Oct'26 to seek shareholder approval for increasing its Authorised Share Capital from ₹11.50 cr to ₹15.00 cr. The expansion involves creating an additional 35,00,000 equity shares of ₹10 each, aggregating to ₹3.50 cr, alongside consequential alterations to Clause V of its Memorandum of Association. The capital expansion aims to enhance financial flexibility to meet future capital requirements and fund growth initiatives. Consolidated voting results scrutinized by Mittal V. Kothari & Associates will be declared within two working days.
Sotac Pharmaceuticals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 31, 2026
Annual General Meeting · 08 Oct 2026, 10:20 pm
Sotac Pharmaceuticals Convenes EOGM to Expand Authorized Share Capital Sotac Pharmaceuticals Limited has issued a notice convening an Extraordinary General Meeting (EOGM) on 31st Oct'26 via video conference to seek shareholder approval for increasing its authorized share capital. The company proposes raising the authorized capital from Rs. 11.50 crore (1.15 crore equity shares of Rs. 10 each) to Rs. 15.00 crore (1.50 crore equity shares of Rs. 10 each) by creating 35.00 lakh additional equity shares to facilitate future equity issuance. Remote e-voting runs from 28th Oct'26 to 30th Oct'26 with a cut-off date of 24th Oct'26.
Sotac Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on October 08, 2026.
Outcome · 08 Oct 2026, 9:34 pm
Sotac Pharmaceuticals Board Approves Increase in Authorized Share Capital The Board of Directors of Sotac Pharmaceuticals approved an increase in the company's authorized share capital from Rs. 11.50 cr (1.15 cr equity shares of Rs. 10 each) to Rs. 15.00 cr (1.50 cr equity shares of Rs. 10 each), subject to shareholder approval, along with corresponding alterations to Clause V of the Memorandum of Association. Additionally, the Board approved the notice for an Extra-Ordinary General Meeting, appointed NSDL for remote e-voting, and engaged M/s. Mittal V. Kothari & Associates as the scrutinizer.
Sotac Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Oct 2026, 12:33 am
Sotac Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 01 Oct 2026, 12:00 am
Sotac Pharmaceuticals Limited has informed the Exchange about Regulation 36(1)(b) of the SEBI Listing Regulations regarding letter to shareholders
Others (Uncategorized) · 09 Sept 2026, 12:49 am
Sotac Pharmaceuticals Dispatches Annual Report FY26 Web-Link and Schedules 11th AGM Sotac Pharmaceuticals Limited has issued web-link intimations for its FY25-26 Annual Report to shareholders without registered email addresses, in compliance with Regulation 36(1)(b) of SEBI LODR. The company's 11th Annual General Meeting is scheduled for 30th Sep'26 at 11:00 AM IST via Video Conferencing. The cut-off date to determine e-voting eligibility is 23rd Sep'26. The remote e-voting window opens on 27th Sep'26 at 9:00 AM IST and concludes on 29th Sep'26 at 5:00 PM IST.
Sotac Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.
Dividend · 09 Sept 2026, 12:03 am
Sotac Pharmaceuticals Announces Record Date for FY26 Final Dividend Sotac Pharmaceuticals has fixed 23rd Sep'26 as the record date to determine shareholder eligibility for a final dividend of Rs. 0.20 per equity share (2.00% of face value of Rs. 10 each) for FY25-26. The dividend is subject to shareholder approval at the company's 11th Annual General Meeting scheduled for 30th Sep'26. Upon approval, the dividend will be disbursed to eligible shareholders on or before 30th Oct'26.
Sotac Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 08 Sept 2026, 11:53 pm
Sotac Pharmaceuticals Limited has informed the Exchange regarding Appointment of M/s. Suthar Haresh & Associates, Cost Auditor of the company w.e.f. April 01, 2026.
Change in Management · 08 Sept 2026, 12:24 am
Sotac Pharmaceuticals Announces AGM, Dividend Record Date, and Cost Auditor Appointment Sotac Pharmaceuticals’ Board has scheduled its 11th AGM for 30th Sep'26 and fixed 23rd Sep'26 as the record date for a dividend of Rs. 0.20 per share (2.00% of Rs. 10 face value) for FY26, payable within 30 days of shareholder approval. Additionally, the Board approved the appointment of M/s. Suthar Haresh & Associates, Cost Accountants, as Cost Auditors for FY27, along with appointing NSDL for remote e-voting and M/s. SCS and CO LLP as the scrutinizer.
Sotac Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026 regarding approval of Draft Directors Report & Notice of 11th Annual General Meeting of the company
Outcome · 08 Sept 2026, 12:18 am
Sotac Pharmaceuticals Limited has informed the Exchange about Bagging/Receiving of orders/contracts.
Others (Uncategorized) · 23 Jul 2026, 5:24 pm
Sotac Pharmaceuticals Wins Rs 97.57 Lakh Order from Intas Pharmaceuticals Sotac Pharmaceuticals secured a purchase order worth Rs 97.57 lakh (exclusive of GST) from Intas Pharmaceuticals on 22 Jul'26. The domestic order is for the supply of finished pharmaceutical formulations, including various strengths of Entacom tablets. This order augments Sotac's existing order book. Deliveries are scheduled on a staggered basis between 05 Sep'26 and 05 Nov'26. The transaction does not involve any promoter group interest or related parties. Payment terms are 30 days from receipt of material.